| Cat.No.: | BSM-0104 |
| Product Name: | CPI-0610 |
| CAS No.: | 1380087-89-7 |
| Figure: |
|
| Synonyms: | (S)-2-(6-(4-chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide |
| Description: | CPI-0610 is a potent, selective BET (bromodomain and extra terminal family of proteins) inhibitor and inhibits BRD4-BD1 with IC₅₀ of 39 nM. It potentially demonstrates anti-neoplastic activity by binding acetylated lysine recognition motifs on the bromodomain of BET proteins, thus preventing the interaction of BET proteins and acetylated histone peptides. |
| Appearance: | White Solid |
| Molecular Weight: | 365.82 |
| Purity: | ≥98% by HPLC |
| Storage: | -20°C |
| Targets: | BET (bromodomain and extra terminal family of proteins) |
| Molecular Formula: | C₂₀H₁₆ClN₃O₂ |
| MDL Number: | MFCD00866266 |
| Solubility: | DMSO(>3 mg/ml) |
| Shipping Conditions: | Gel Pack |
| Warning: | For Research Use Only! Not For Use in Humans. |
USA
Enter your email here to subscribe.
Follow us on
Easy access to products and services you need from our library via powerful searching tools
